Compare SMTI & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMTI | PANL |
|---|---|---|
| Founded | 1982 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 313.5M | 485.4M |
| IPO Year | 2008 | 2015 |
| Metric | SMTI | PANL |
|---|---|---|
| Price | $34.40 | $8.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $34.00 | $9.00 |
| AVG Volume (30 Days) | ★ 425.7K | 357.1K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | $15,586,976.00 | ★ $385,088,209.00 |
| Revenue This Year | $17.31 | $0.72 |
| Revenue Next Year | $12.48 | N/A |
| P/E Ratio | ★ N/A | $21.94 |
| Revenue Growth | ★ 32.47 | N/A |
| 52 Week Low | $16.05 | $4.56 |
| 52 Week High | $35.70 | $9.39 |
| Indicator | SMTI | PANL |
|---|---|---|
| Relative Strength Index (RSI) | 79.57 | 65.66 |
| Support Level | $33.68 | $7.99 |
| Resistance Level | N/A | $8.43 |
| Average True Range (ATR) | 0.22 | 0.25 |
| MACD | -0.28 | 0.07 |
| Stochastic Oscillator | 95.77 | 96.90 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Pangaea Logistics Solutions Ltd and its subsidiaries collectively, Pangaea or the Company, provide seaborne drybulk logistics and transportation services as well as terminal and stevedoring services. Pangaea utilizes its logistics expertise to service a broad base of industrial customers who require the transportation of a wide variety of dry bulk cargoes, including grains, coal, iron ore, pig iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The Company's operating segments include the shipping segment: The Company's operating segments include the shipping segment and six terminal and stevedoring operating segments. The company operates in the USA, Germany, Canada, Singapore, the United Kingdom, and other countries, with maximum from the USA and others.